| BSE: 538965 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE858L01010 |
| BSE 00:00 | 13 Feb | 17.60 |
0 (0.00%) |
OPEN
17.70 |
HIGH
17.70 |
LOW
17.60 |
| NSE 05:30 | 01 Jan | Concord Drugs Ltd |
| OPEN | 17.70 |
| PREVIOUS CLOSE | 17.60 |
| VOLUME | 6 |
| 52-Week high | 23.50 |
| 52-Week low | 12.35 |
| P/E | 31.43 |
| Mkt Cap.(Rs cr) | 14 |
| Buy Price | 17.35 |
| Buy Qty | 96.00 |
| Sell Price | 17.50 |
| Sell Qty | 52.00 |
CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilitie...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
14 | |
| EPS - TTM | () |
[*S] | 0.56 |
| P/E Ratio | (X) | [*S] | 31.43 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 28.58 |
| P/B Ratio | () |
[*S] | 0.62 |
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31.12.2019
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Statement Of Investor Complaints For The Quarter Ended December 2019
Revised Financial Statements For The Financial Year Ended 31.03.2018
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 10.91 | 9.21 | 18.46 |
| Other Income | 0.02 | 0.02 | 0 |
| Total Income | 10.93 | 9.23 | 18.42 |
| Total Expenses | 10.09 | 8.23 | 22.6 |
| Operating Profit | 0.83 | 1 | -17 |
| Net Profit | 0.04 | 0.04 | 0 |
| Equity Capital | 8.74 | 7.86 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Syschem (India) | 8.46 | -2.76 | 15.90 |
| Ind-Swift | 2.76 | 1.47 | 14.95 |
| Ortin Labs. | 8.36 | -3.91 | 14.16 |
| Godavari Drugs | 17.50 | 5.11 | 13.18 |
| Parnax Lab | 14.50 | -1.69 | 12.32 |
| Medi Caps | 9.36 | 2.74 | 11.67 |
| Sandu Pharma. | 15.20 | -4.10 | 10.76 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -1.95% | NA | 0.19% | 0.12% |
| 1 Month | 14.66% | NA | -2.12% | -2.48% |
| 3 Month | -2.22% | NA | 1.73% | 1.26% |
| 6 Month | 7.32% | NA | 9.92% | 9.03% |
| 1 Year | 5.71% | NA | 14.65% | 12.32% |
| 3 Year | -72.09% | NA | 44.21% | 36.55% |
| Today's Low/High | 17.60 |
|
17.70 |
| Week Low/High | 17.35 |
|
19.00 |
| Month Low/High | 14.75 |
|
19.00 |
| YEAR Low/High | 12.35 |
|
24.00 |
| All TIME Low/High | 12.35 |
|
91.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
